GlassScriptPhysician profile
Todd W Flannery
NPI 1033253679
$1,428.04
in general payments reported to CMS, 2019-2025
21 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $264 · 2020: $13.92 · 2021: $14.35 · 2022: $511 · 2023: $438 · 2024: $59.22 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $625.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $624.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $196.82 | 2022-2025 | Enhertu, Injectafer |
| Novocure INC. | $143.17 | 2019 | |
| Exelixis INC. | $128.47 | 2022 | |
| Epizyme, INC. | $125.00 | 2022 | |
| Karyopharm Therapeutics INC. | $124.99 | 2023 | Xpovio |
| Astrazeneca Pharmaceuticals LP | $120.46 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $97.98 | 2023 | Opdivo |
| Blueprint Medicines Corporation | $93.47 | 2023 | Ayvakit |
| Amgen INC. | $90.21 | 2022 | |
| Pfizer INC. | $58.64 | 2025 | |
| Abbvie INC. | $53.14 | 2023-2025 | |
| Boston Scientific Corporation | $44.15 | 2023-2025 | Spaceoar System, Spaceoar Vue System - 10ml |
| Tempus Ai, INC | $23.82 | 2024 | Xt Cdx |
| Seagen INC. | $20.00 | 2023 | Adcetris |
| Springworks Therapeutics, INC. | $18.63 | 2024 | Ogsiveo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kyowa Kirin, INC. | $16.68 | 2023 | Poteligeo |
| Lilly USA, LLC | $16.56 | 2023 | Verzenio |
| Kite Pharma, INC. | $15.08 | 2025 | Yescarta |
| Glaxosmithkline, LLC. | $14.35 | 2021 | |
| Jazz Pharmaceuticals INC. | $13.92 | 2020 | |
| Myovant Sciences INC. | $12.50 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Todd Flannery listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.